Schrodinger Inc
NASDAQ:SDGR
Intrinsic Value
Schrödinger, Inc. engages in the provision of chemical simulation software solutions to pharmaceutical industry. [ Read More ]
The intrinsic value of one SDGR stock under the Base Case scenario is 16.39 USD. Compared to the current market price of 24.05 USD, Schrodinger Inc is Overvalued by 32%.
Valuation Backtest
Schrodinger Inc
Run backtest to discover the historical profit from buying and selling SDGR stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Schrodinger Inc
Current Assets | 567.8m |
Cash & Short-Term Investments | 463m |
Receivables | 89.1m |
Other Current Assets | 15.7m |
Non-Current Assets | 235.2m |
Long-Term Investments | 83.3m |
PP&E | 141.1m |
Intangibles | 4.8m |
Other Non-Current Assets | 6m |
Current Liabilities | 133.7m |
Accounts Payable | 16.8m |
Accrued Liabilities | 60.6m |
Other Current Liabilities | 56.2m |
Non-Current Liabilities | 120.7m |
Other Non-Current Liabilities | 120.7m |
Earnings Waterfall
Schrodinger Inc
Revenue
|
216.7m
USD
|
Cost of Revenue
|
-76m
USD
|
Gross Profit
|
140.7m
USD
|
Operating Expenses
|
-318.1m
USD
|
Operating Income
|
-177.4m
USD
|
Other Expenses
|
218.2m
USD
|
Net Income
|
40.7m
USD
|
Free Cash Flow Analysis
Schrodinger Inc
SDGR Profitability Score
Profitability Due Diligence
Schrodinger Inc's profitability score is 35/100. The higher the profitability score, the more profitable the company is.
Score
Schrodinger Inc's profitability score is 35/100. The higher the profitability score, the more profitable the company is.
SDGR Solvency Score
Solvency Due Diligence
Schrodinger Inc's solvency score is 79/100. The higher the solvency score, the more solvent the company is.
Score
Schrodinger Inc's solvency score is 79/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
SDGR Price Targets Summary
Schrodinger Inc
According to Wall Street analysts, the average 1-year price target for SDGR is 38.45 USD with a low forecast of 26.26 USD and a high forecast of 52.5 USD.
Ownership
SDGR Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
SDGR Price
Schrodinger Inc
Average Annual Return | 24.59% |
Standard Deviation of Annual Returns | 132.48% |
Max Drawdown | -86% |
Market Capitalization | 1.7B USD |
Shares Outstanding | 72 310 000 |
Percentage of Shares Shorted | 11.41% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Schrödinger, Inc. engages in the provision of chemical simulation software solutions to pharmaceutical industry. The company is headquartered in New York City, New York and currently employs 664 full-time employees. The company went IPO on 2020-02-06. The firm operates through two segments: Software and Drug Discovery. The Software segment is focused on licensing the Company’s software for molecular discovery. The Drug Discovery segment is focused on building a portfolio of preclinical and clinical drug programs, internally and through collaborations. The Company’s physics-based software platform enables discovery of molecules for drug development and materials applications. Its software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories. The Company’s pipeline includes CDC7, Wee1, MALT1, HIF-2 alpha and SOS1/KRAS. Its CDC7 is a small molecule inhibitor for treatment of solid and liquid tumors.
Contact
IPO
Employees
Officers
The intrinsic value of one SDGR stock under the Base Case scenario is 16.39 USD.
Compared to the current market price of 24.05 USD, Schrodinger Inc is Overvalued by 32%.